Table 2.
Demographic information and results of studies included in the systematic review.
ED screening tool |
n | Age (yrs) Mean ± SD | BMI (kg/m2) Mean ± SD | ED score Mean ± SD Prevalence of abnormal screening score n(%) |
Prevalence of specific ED diagnoses n (%) |
Demographic characteristics/ recruitment locationa | ||||
---|---|---|---|---|---|---|---|---|---|---|
PCOS | Control | PCOS | Control | |||||||
Lee et al, 2016 (USA) | EDE-Q NEQ |
148 | 106 | P: 28.1 ± 5.2** C: 31.9 ± 8.1** | P: 33.9 ± 9.9** C: 26.8 ± 7.5** |
EDE-Q Global: 2.38 ± 1.31** NEQ: 16.67 ± 6.18 Abnormal EDE-Q Score: 18 (12.2)* Abnormal NEQ Score: 19 (12.9) |
EDE-Q Global: 1.29 ± 1.09** NEQ: 14.88 ± 5.43 Abnormal EDE-Q Score: 3 (2.8)* Abnormal NEQ Score: 7 (6.6) |
AN: 0 (0) BN: 9 (6.1) BED: 26 (17.6) NES: 19 (12.9) |
AN: 0 (0) BN: 6 (5.7) BED: 11 (10.4) NES: 13 (12.38) |
White race (P)*, income, employed, education, married (P)* P: PCOS center C: gynecology clinic |
Jeanes et al, 2016 (UK)b | BITE | 45c | 40 | P: 31.3 ± 5.6 C: 28.3 ± 8.5 |
P: 22.5 ± 1.8 C: 21.8 ± 1.6 |
BITE Binge Eating Symptom Score: 10.9 ± 7.8* Abnormal Score: 16 (36)* |
BITE Binge Eating Symptom Score: 7.4 ± 6.0* Abnormal Score: 5 (12)* |
Not reported | Not reported | No demographics reported P, C: online advertisements in university |
Bernadett et al 2016 (Hungary) | EAT-26 | 95 | 100 | P: 29.8± 4.9** C: 27.6 ± 6.6** |
P: 26.1 ± 2.6** C: 22.1 ± 3.6** | Mean score not reported Abnormal Score: 40 (43.0)** |
Mean score not reported Abnormal Score: 12 (12.4)** |
AN: 0 (0) BN: 5 (5.3) |
AN: 0 (0) BN: 0 (0) |
No demographics reported P: PCOS foundation, health center, online forums C: advertisements in university |
Larsson et al, 2015 (Sweden) | TFEQ-R21; EAT-40 | 72 | 30 | P: 30.2 ± 4.4** C: 27.8 ± 3.6** | P: 28.5 ± 7.2** C: 24.6 ± 5.0** |
TFEQ Cognitive restraint: 41±23 Uncontrolled eating: 42±20 Emotional eating: 44±28 EAT-40: 16.4± 10.1 *** EAT-40 Abnormal Score: 6 (8.3) |
TFEQ Cognitive restraint: 37±23 Uncontrolled eating: 39±15 Emotional eating: 37±19 EAT-40: 7.8±6.7*** EAT-40 Abnormal Score: 1 (3.3) |
Not reported | Not reported | No demographics reported P, C: community advertisements |
Karacan et al, 2014 (Turkey)d | EAT-26 | 42 | 52 | P: 19.1 ±2.3 C: 19.7±2.1 |
P: 22.4±3.8 C: 21.4±3.82 |
EAT-26: 46.6±17.0 Abnormal Score: 15 (35.7) |
EAT-26: 48.2±17.6 Abnormal Score: 16 (30.8) |
Not reported | Not reported | Socioeconomic status, income, participant education (C)*, parental education P, C: gynecology clinic |
Batcheller et al, 2013 (USA) | DSM- based survey |
11 | 10 | 29.7 ± 3.0 (not separated by group) | 28.0 ± 7.5 (not separated by group) | Not reported | Not reported | BED: 0 (0) | BED: 0 (0) | No demographics reported P, C: fertility center |
Mansson et al, 2008 (Sweden) | MINI | 49 | 49 | P: 35.9 ± 10.4 C: 35.9 ± 10.4 |
P: 29.1 ± 7.4** C: 23.5 ± 3.0** | Not reported | Not reported |
Any EDe: 10 (21)* BN: 6 (12) |
Any ED: 2 (4)* BN: 2 (4) |
Overall employment statusf, employed or student (C)*, education, married or cohabitating P: gynecology clinic C: population registry |
Hollinrake et al, 2007 (USA) | PRIME-MD PHQ | 103 | 103 | P: 29.8 ± 6.2 C: 30.7± 8.5 |
P: 34.9 ± 8.5* C: 25.4 ± 4.7* |
Not reported | Not reported |
BED: 13 (12.6)** |
BED: 2 (1.9)** |
Race, employed, education, married, currently attempting pregnancy (P)** P: reproductive and infertility clinic C: gynecology clinic |
P: PCOS group; C: control group
p<0.05
p<0.01
p<0.01 after adjusting for age and BMI
Reported demographic characteristics and significant differences between groups: (P): greater prevalence of demographic characteristic in PCOS participants; (C): greater prevalence of demographic characteristic in controls
Excluded from metaanalysis due to self-report of PCOS diagnosis
Only lean PCOS participants were included in this table
Author provided unpublished information
MINI based on DSM-IV includes AN, BN, and AN binge/purge type
No difference in overall employment status, but PCOS participants were more likely to receive sick benefits (p<0.05)